Physician profile
Patrick Ellender
NPI 1841469681
$6,224.25
in general payments reported to CMS, 2019-2025
22 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $1,328 · 2021: $421 · 2022: $2,311 · 2023: $266 · 2024: $387 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179 · Travel and Lodging: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.44 |
| Travel and Lodging | $738.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,619.24 | 2019-2025 | Inspace, 1788, Blueprint Patient Specific Instrumentation |
| Alon Medical Technology | $1,809.47 | 2020-2025 | |
| Arthrex, INC. | $766.44 | 2025 | |
| Pacira Therapeutics, INC. | $202.43 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $159.99 | 2019-2024 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $134.43 | 2020-2024 | Tapestry |
| Pacira Pharmaceuticals Incorporated | $117.69 | 2022-2025 | Iovera, Exparel, Zilretta |
| Sanofi-Aventis U.S. LLC | $56.39 | 2019-2023 | |
| Depuy Synthes Sales INC. | $42.34 | 2021 | |
| Radius Health, INC. | $41.39 | 2019-2021 | |
| Amgen INC. | $33.64 | 2019 | |
| Davol INC. | $30.97 | 2022 | |
| Abbvie INC. | $28.73 | 2022-2024 | |
| Smith+Nephew, INC. | $27.02 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $24.96 | 2023 | Seglentis |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $22.84 | 2024 | Zynrelef |
| Kci USA, INC. | $22.48 | 2020 | |
| Convatec INC. | $21.72 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $18.55 | 2021 | |
| Baudax Bio INC. | $16.57 | 2020 | |
| Horizon Therapeutics Plc | $15.33 | 2020 | |
| Pfizer INC. | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Ellender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.